Select Species Dataset
Sotalol
Supraventricular Tachyarrhythmia
No Recommendations
There is no community consensus on diagnosing or staging any rabbit cardiac disease. Therefore, until our understanding of rabbit cardiovascular disease is better developed, identifying ideal target patients, therapeutic strategies, and assessing our treatment efficacy remains elusive.
Major species extrapolation (MSE) and anecdotal expert opinion in textbooks at 1.7 mg/kg, PO, q12h inform all dosing suggestions identified (Müller and Mancinelli, 2022; Ozawa et al., 2021).
No clear evidence base supports the beneficial use of Sotalol in rabbits with Ventricular Arrhythmias, and any assumption that Sotalol may improve outcomes is unclear.
Formulations
Ozawa, S., Guzman, D.S.-M., Keel, K., Gunther-Harrington, C., 2021. Clinical and pathological findings in rabbits with cardiovascular disease: 59 cases (2001–2018). Journal of the American Veterinary Medical Association 259, 764–776. https://doi.org/10.2460/javma.259.7.764